Kingfa Science & Technology (India) Ltd
- P/E
- 41.2x
- 52-week range
- 3,649.9 – 6,997
- ROE
- 17%
- ROCE
- 23%
- Sector
- Industrial Products
- Industry
- Plastic Products - Industrial
- Listed on
- NSE, BSE
About
Kingfa Science & Technology (India) Limited is an India-based company, which is engaged in the business of manufacturing and supplying reinforced polypropylene compounds, thermoplastic elastomers, fiber re-enforced composites and personal protective equipment (PPE) like masks and gloves. The Company operates through a single segment, Reinforced Polypropylene. The Company's products include Polymer Compounding, and Personal Protective Equipment. Its Personal Protective Equipment includes Respiratory Protection (MFR), Respiratory Protection (Reusable), Hand Protection, Eye Protection, and Protective Cover. Its Polypropylene modified by the addition of reinforcements, such as talc, chalk, mica, and glass fiber and has enabled it to establish itself as a metal substitute in engineering applications. Its Engineering Plastics Compounds are used in automobiles, electronic appliances, industrial equipment, consumer goods, packaging, toys, and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Plastic Products - Industrial: 78 companies →Kingfa Science & Technology (India) Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)41.2 against a typical 20.5: pricier than most peers (1st = cheapest).60th of 76
- Sales growth+49.1% against a typical +14.5% from a year earlier.9th of 66
- Profit growth+100% against a typical +15.3% from a year earlier.9th of 55
- Share price, 3 months+36.1% against a typical −8.5%.5th of 61
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 14 Aug 2026 | Financial Results/Dividend/Other business matters | The meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve:1. To consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2026. 2. To consider and recommend the final dividend for the Financial Year ended March 31, 2026 |
| 29 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 7 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 12 Nov 2025 | Financial Results | To consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2025 and any other matter with permission of the Chair. |
| 22 Aug 2025 | Fund Raising | Prior intimation of Board Meeting under Regulation 29(1)(d) of the SEBI (LODR) Regulations, 2015 |
| 30 Jul 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 351 | 394 | 404 | 416 | 418 | 440 | 470 | 462 | 466 | 489 | 578 | 689 |
| Expenses | 306 | 356 | 354 | 359 | 362 | 389 | 409 | 404 | 405 | 428 | 497 | 578 |
| Operating Profit | 45 | 38 | 51 | 57 | 56 | 51 | 60 | 58 | 61 | 62 | 81 | 111 |
| OPM % | 13% | 10% | 13% | 14% | 13% | 12% | 13% | 13% | 13% | 13% | 14% | 16% |
| Other Income | 0 | 1 | 2 | 2 | 1 | 5 | 2 | 4 | 3 | 7 | 7 | 5 |
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 8 | 8 |
| Profit before tax | 40 | 32 | 45 | 52 | 50 | 49 | 54 | 54 | 55 | 61 | 80 | 108 |
| Tax % | 25% | 25% | 26% | 25% | 26% | 30% | 23% | 26% | 26% | 26% | 26% | 25% |
| Net Profit | 30 | 24 | 34 | 39 | 37 | 35 | 42 | 40 | 41 | 45 | 59 | 80 |
| EPS in Rs | 24.44 | 20.09 | 27.7 | 32.26 | 30.77 | 28.6 | 34.6 | 32.86 | 30.36 | 33.33 | 43.65 | 59.19 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 20%
- 5 Years
- 26%
- 3 Years
- 12%
- TTM
- 24%
- 10 Years
- 33%
- 5 Years
- 103%
- 3 Years
- 32%
- TTM
- 47%
- 10 Years
- 19%
- 5 Years
- 40%
- 3 Years
- 35%
- TTM
- —
- 10 Years
- 15%
- 5 Years
- 19%
- 3 Years
- 20%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Kingfa Science & Technology (India) Ltd | ₹ 6,872.00 | — | 41.2x | — | 17% | — |
| Gujarat Fluorochemicals | ₹ 4,241.25 | ₹ 47,986 Cr. | 88.7x | 6.7x | 0% | 0% |
| DCM Shriram | ₹ 962.10 | ₹ 14,996 Cr. | 17.5x | 2x | 0% | 0% |
| Supreme Petrochem | ₹ 710.10 | ₹ 13,338 Cr. | 45.7x | 6.5x | 0% | 0% |
| Shaily Engineering Plastics | ₹ 2,953.20 | ₹ 13,594 Cr. | 89.1x | 21x | 0% | 0% |
| Kama Holdings | ₹ 2,120.00 | ₹ 6,803 Cr. | 7.2x | 0.9x | 0% | 0% |
Management
- Dazhong Wang
- Chairman of the Board, Managing Director
- Dongming Xie
- Chief Financial Officer
- Sethuraman Shanmugasundaram
- Chief Operating Officer, Whole-Time Director
- Deepak Vyas
- Compliance Officer, Company Secretary
- Doraiswami Balaji
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.